A Connecticut federal court Judge upheld the Inflation Reduction Act’s Medicare drug negotiation process, knocking down claims of constitutional violations.
Other jurisdictions, such as New Jersey and Delaware, have struck down similar arguments brought by big pharmaceutical companies.
